N@N

Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at Barclays Capital Global Healthcare Conference

^{Published on 2009-03-09 04:34:47, Last Modified on 2009-03-09 04:35:16 - Market Wire}
 

SAN DIEGO, CA--(Marketwire - March 9, 2009) - Cypress Bioscience, Inc. (NASDAQ: [ CYPB ]) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Barclays Capital Global Healthcare Conference on March 11, 2009.

The Barclays conference is being held at the Loews Miami Beach Hotel, Miami Beach, FL. Ms. Johnson is scheduled to present on Wednesday, March 11th at 8:30 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at [ http://cc.talkpoint.com/barc002/030909a_rb/?entity=78_P8WPL82 ].

A replay of the presentation will be available at the same web address as well as on Cypress' website, [ http://www.cypressbio.com/events.php ].

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella™ (milnacipran HCl) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].